| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bacterial infections of respiratory and gastrointestinal mucosae
|
Manning, Paul
|
|
1990
|
8 |
S1 |
p. S140-S141
2 p.
|
article
|
| 2 |
Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage
|
Poovorawan, Y.
|
|
1990
|
8 |
S1 |
p. S56-S59
4 p.
|
article
|
| 3 |
Controlling hepatitis B virus transmission in North America
|
Hollinger, F.B
|
|
1990
|
8 |
S1 |
p. S122-S128
7 p.
|
article
|
| 4 |
Development and production aspects of a recombinant yeast-derived hepatitis B vaccine
|
Stephenne, J.
|
|
1990
|
8 |
S1 |
p. S69-S73
5 p.
|
article
|
| 5 |
Development of recommendations for control of hepatitis B virus infections: the role of cost analysis
|
Margolis, H.S.
|
|
1990
|
8 |
S1 |
p. S81-S85
5 p.
|
article
|
| 6 |
Editorial
|
|
|
1990
|
8 |
S1 |
p. S4-
1 p.
|
article
|
| 7 |
Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients
|
Bruguera, M.
|
|
1990
|
8 |
S1 |
p. S47-S49
3 p.
|
article
|
| 8 |
Efficacy of vaccination: Discussion
|
|
|
1990
|
8 |
S1 |
p. S60-S62
3 p.
|
article
|
| 9 |
Epidemiology and erdication strategy for hepatitis B in Europe
|
Goudeau, A
|
|
1990
|
8 |
S1 |
p. S113-S116
4 p.
|
article
|
| 10 |
Eradication strategies for HBV: Discussion, part 1
|
|
|
1990
|
8 |
S1 |
p. S93-S94
2 p.
|
article
|
| 11 |
Eradication strategies for HBV: Discussion, part 2
|
Blumberg, Baruch S.
|
|
1990
|
8 |
S1 |
p. S134-S139
6 p.
|
article
|
| 12 |
Hepatitis B: global importance and need for control
|
Maynard, J.E.
|
|
1990
|
8 |
S1 |
p. S18-S20
3 p.
|
article
|
| 13 |
Hepatitis B infection in sub-Saharan Africa
|
Kiire, C.F.
|
|
1990
|
8 |
S1 |
p. S107-S112
6 p.
|
article
|
| 14 |
Hepatitis B in Latin America: epidemiological patterns and eradication surgery
|
Fay, O.H
|
|
1990
|
8 |
S1 |
p. S100-S106
7 p.
|
article
|
| 15 |
Hepatitis B surface antigen reactivity in man due to a new variant of hepatitis B virus
|
Coursaget, P.
|
|
1990
|
8 |
S1 |
p. S15-S17
3 p.
|
article
|
| 16 |
Hepatitis B: the disease
|
Sherlock, S.
|
|
1990
|
8 |
S1 |
p. S6-S9
4 p.
|
article
|
| 17 |
Hepatitis B: transmission by sexual contact and needle sharing
|
Piot, P.
|
|
1990
|
8 |
S1 |
p. S37-S40
4 p.
|
article
|
| 18 |
Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus
|
Blumberg, B.S.
|
|
1990
|
8 |
S1 |
p. S86-S92
7 p.
|
article
|
| 19 |
Hepatitis B virus eradication strategy for Asia
|
Sung, J.L
|
|
1990
|
8 |
S1 |
p. S95-S99
5 p.
|
article
|
| 20 |
Hepatitis B virus infection and health care workers
|
Hadler, S.C.
|
|
1990
|
8 |
S1 |
p. S24-S28
5 p.
|
article
|
| 21 |
Hepatitis B virus infection in children
|
Yeoh, E.K.
|
|
1990
|
8 |
S1 |
p. S29-S30
2 p.
|
article
|
| 22 |
Hepatitis delta virus as a global health problem
|
Rizzetto, M.
|
|
1990
|
8 |
S1 |
p. S10-S14
5 p.
|
article
|
| 23 |
Immunogenicity of a recombinant DNA hepatitis B vaccine in institutionalized patients with Down's syndrome
|
Van Damme, P.
|
|
1990
|
8 |
S1 |
p. S53-S55
3 p.
|
article
|
| 24 |
Impact of hepatitis B: Discussion
|
|
|
1990
|
8 |
S1 |
p. S21-S23
3 p.
|
article
|
| 25 |
International Conference on Prospects for eradication of hepatitis B virus
|
Blumberg, Baruch S.
|
|
1990
|
8 |
S1 |
p. S5-
1 p.
|
article
|
| 26 |
Modes of transmission and risk groups: Discussion
|
|
|
1990
|
8 |
S1 |
p. S41-S43
3 p.
|
article
|
| 27 |
Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine
|
André, F.E.
|
|
1990
|
8 |
S1 |
p. S74-S78
5 p.
|
article
|
| 28 |
Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules
|
Scheiermann, N.
|
|
1990
|
8 |
S1 |
p. S44-S46
3 p.
|
article
|
| 29 |
Protective efficacy of a recombinant DNA vaccine against hepatitis B in male homosexuals: results at 36 months
|
Goilav, C.
|
|
1990
|
8 |
S1 |
p. S50-S52
3 p.
|
article
|
| 30 |
Protective potential of hepatitis B virus antigens other than the S gene protein
|
Gerlich, W.H.
|
|
1990
|
8 |
S1 |
p. S63-S68
6 p.
|
article
|
| 31 |
Recombinant DNA vaccines: Discussion
|
|
|
1990
|
8 |
S1 |
p. S79-S80
2 p.
|
article
|
| 32 |
Risks of hepatitis B for travellers
|
Steffen, R.
|
|
1990
|
8 |
S1 |
p. S31-S32
2 p.
|
article
|
| 33 |
Strategy for the control of hepatitis B virus infection in the Middel East and North Africa
|
Toukan, A
|
|
1990
|
8 |
S1 |
p. S117-S121
5 p.
|
article
|
| 34 |
The military and hepatitis B
|
Bancroft, W.H.
|
|
1990
|
8 |
S1 |
p. S33-S36
4 p.
|
article
|
| 35 |
WHO strategy for the global elimination of new cases of hepatitis B
|
Ghendon, Y.
|
|
1990
|
8 |
S1 |
p. S129-S133
5 p.
|
article
|
Journal description